Agomab Therapeutics director Naimish Patel files initial beneficial ownership statement
AGMB•Initial Form 3 filing names new director
Agomab Therapeutics filed an initial Form 3 naming Naimish Patel as a director, marking his entry into SEC insider reporting.
